Modern approaches to diagnosis, treatment and prevention of postpartum hemorrhage (literature review)
DOI:
https://doi.org/10.15574/HW.2024.5(174).5465Keywords:
postpartum hemorrhage, massive obstetric hemorrhage, uterotonic agents, tranexamic acid, conservative hemostasis, surgical hemostasis, ligation of major vesselsAbstract
Postpartum hemorrhage (PPH) remains one of the main causes of maternal morbidity and mortality worldwide, despite the progress of medical science and the introduction of new methods of diagnosis and therapy of hemorrhagic complications during pregnancy, childbirth and the postpartum period.
Aim - to familiarize the general public with the latest recommendations of the International Federation of Gynecology and Obstetrics (FIGO, 2022) and our own experience regarding the most effective and evidence-based methods of diagnosis, therapy and prevention of PPH.
Postpartum hemorrhage is classified into primary (early), which occurs when more than 500 ml of blood is lost during the first 24 hours after childbirth, and secondary (late), which occurs after 24 hours and up to 6 weeks after childbirth. The initial examination of the patient should include a rapid clinical assessment and analysis of risk factors. In order to objectify the volume of blood loss according to FIGO recommendations, the shock index (SI) should be used. Treatment should be directed at the specific cause of PPH (uterine atony, genital trauma, retained placenta and/or coagulopathy), and therapeutic steps should move from a less invasive method to a more complex and radical approach. In the case of refractory PPH, it is necessary to use the most effective modern methods of surgical hemostasis: ligation of the main uterine vessels, compression sutures on the uterus, bilateral ligation of the internal iliac arteries, methods of remodeling the lower uterine segment (LUS-1,2). The paradigm of infusion-transfusion therapy for massive PPH has changed, which is based on the concept of damage control resuscitation (DCR), which is based on warming the parturient, limited use of crystalloids, permissive hypotension tactics, early initiation of blood product transfusion, use of massive blood transfusion protocols, and targeted correction of coagulopathy. PPH prevention strategies include prenatal identification of risk factors, correction of anemia during pregnancy, active management of the third stage of labor, and intravenous administration of tranexamic acid.
Conclusions. The implementation of the latest FIGO recommendations for the prevention, diagnosis, and treatment of PPH in the practice of obstetric facilities in the country will contribute to reducing maternal morbidity and mortality.
The authors declare no conflict of interest.
References
Ai W, Zeng Y, Zhen M, Lao L, Ma Y, Liu L, Zhang Y. (2023). Side-effects of intravenously versus intramuscularly oxytocin for postpartum hemorrhage: a systematic review and meta-analysis of randomized controlled trials. Front. Pharmacol. 14: 1273771. https://doi.org/10.3389/fphar.2023.1273771; PMid:38186656 PMCid:PMC10770861
Arulkumaran S, Karoshi M, Keith LG, Lalonde AB, Sapiens ChB-L. (2012). A Comprehensive Textbook of Postpartum Hemorrhage: An Essential Clinical Reference for Effective Management: 633.
Atukunda EC, Mugyenyi GR, Obua C, Atuhumuza EB, Musinguzi N, Tornes YF et al. (2016). Measuring post-partum haemorrhage in low-resource settings: The diagnostic validity of weighed blood loss versus quantitative changes in hemoglobin. PLoS One. 11(4): e0152408. https://doi.org/10.1371/journal.pone.0152408; PMid:27050823 PMCid:PMC4822885
Begley CM, Gyte GM, Devane D, McGuire W, Weeks A, Biesty LM. (2019, Feb 13). Active versus expectant management for women in the third stage of labour. Cochrane Database Syst Rev. 2(2): CD007412. https://doi.org/10.1002/14651858.CD007412.pub5; PMid:30754073 PMCid:PMC6372362
Bienstock JL, Eke AC, Hueppchen NA. (2021). Postpartum hemorrhage. N Engl J Med. 384: 1635-1645. https://doi.org/10.1056/NEJMra1513247; PMid:33913640 PMCid:PMC10181876
Cannon JW. (2018). Hemorrhagic shock. N Engl J Med. 378: 370-379. https://doi.org/10.1056/NEJMra1705649; PMid:29365303
Cherkas D. (2011). Traumatic hemorrhagic shock: advances in fluid management. Emerg Med Pract. 13(11): 1-19 quiz 19-20.
Chernov AV, Kaminsky VV, Goianovskyy OV. (2014). Postpartum blood loss: challenges of estimation, true volume and problems of unified definition. Health of woman. 10(96): 26-31.
Committee on Practice Bulletins-Obstetrics. (2017, Oct). Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 130(4): e168-e186. https://doi.org/10.1097/AOG.0000000000002351; PMid:28937571
Cunningham C, Watt P, Aflaifel N, Collins S, Lambert D, Porter J et al. (2017, Feb). PPH Butterfly: a novel device to treat postpartum haemorrhage through uterine compression. BMJ Innov. 3(1): 45-54. Epub 2017 Jan 2. https://doi.org/10.1136/bmjinnov-2016-000144; PMid:28250966 PMCid:PMC5293860
Escobar MF, Anwar HN, Theron G et al. (2022). FIGO recommendations on the management of postpartum hemorrhage 2022. Int J Gynecol Obstet. 157; Suppl 1: 3-50. https://doi.org/10.1002/ijgo.14116; PMid:35297039 PMCid:PMC9313855
Gillissen A, van den Akker T, Caram-Deelder C et al. (2018). Association between fluid management and dilutional coagulopathy in severe postpartum haemorrhage: nationwide retrospective cohort study. BMC Pregn Childbirth. 18: 398. https://doi.org/10.1186/s12884-018-2021-9; PMid:30305108 PMCid:PMC6180574
Golianovskyi O, Dziuba D, Morozova O, Herasymova T, Voloshyn O, Holenia I, Kononets O. (2023). Suchasnyi pidkhid do transfuziinoi terapii masyvnykh krovotech za naiavnosti anomalno invazyvnoi platsenty. Reproduktyvne zdorovia zhinky. (5): 39-45. https://doi.org/10.30841/2708-8731.5.2023.286768
Golyanovskiy OV, Himenko MV, Galich ID, Slobodyan IV. (2015). Postpartum haemorrhage: etiology, pathogenesis, prevention and contemporary treatment. Health of woman. 8(104): 11-18.
Golianovskyi OV, Leush SS, Romanenko TH. i spivavt. (2013). Krovotechi v praktytsi akushera-hinekoloha. Navchalnyi posibnyk. Kyiv: 240.
Govsieiev DO, Berestovyi VO, Vorona RM, Sokol IV, Makarenko MV. (2017). Sposib zupynky krovotechi u porodilli pislia kesarevoho roztynu. Patent Ukrainy No. 117714. URL: https://uapatents.com/ua/patent/117714
Haslinger C, Weber K, Zimmermann R. (2021, Sep 1). Vacuum-Induced Tamponade for Treatment of Postpartum Hemorrhage. Obstet Gynecol. 138(3): 361-365. https://doi.org/10.1097/AOG.0000000000004510; PMid:34352848 PMCid:PMC8366764
Heesen M, Carvalho B, Carvalho JCA, Duvekot JJ, Dyer RA, Lucas DN et al. (2019, Oct). International consensus statement on the use of uterotonic agents during caesarean section. Anaesthesia. 74(10): 1305-1319. Epub 2019 Jul 25. https://doi.org/10.1111/anae.14757; PMid:31347151
Henriquez DDCA, Bloemenkamp KWM, Loeff RM et al. (2019). Fluid resuscitation during persistent postpartum haemorrhage and maternal outcome: a nationwide cohort study. Eur J Obstet Gynecol Reprod Biol. 235: 49-56. https://doi.org/10.1016/j.ejogrb.2019.01.027; PMid:30784827
Hofer S, Blaha J, Collins PW, Ducloy-Bouthors AS, Guasch E, Labate F et al. (2023, Jan 1). Haemostatic support in postpartum haemorrhage: A review of the literature and expert opinion. Eur J Anaesthesiol. 40(1): 29-38. Epub 2022 Sep 22. https://doi.org/10.1097/EJA.0000000000001744; PMid:36131564 PMCid:PMC9794135
Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT. (2022, Mar). Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents. Am J Obstet Gynecol. 226(3): 347-365. Epub 2021 Sep 14. https://doi.org/10.1016/j.ajog.2021.08.060; PMid:34534498
Kaya B, Damarer Z, Daglar K, Unal O, Soliman A, Guralp O. Is there yet a role for internal iliac artery ligation in obstetric hemorrhage with the current gain in popularity of other uterus sparing tech- niques? J Matern Fetal Neonatal Med. 2017;30(11):1325-1332. https://doi.org/10.1080/14767058.2016.1212333; PMid:27405790
Kaminskyi VV, Holianovskyi OV, Tkachenko RO, Chernov AV. (2010). Masyvni akusherski krovotechi. Pid red. VV Kaminskoho. Kyiv: RVA «Triumf»: 210.
Kogutt BK, Vaught AJ. (2019). Postpartum hemorrhage: Blood product management and massive transfusion. Semin Perinatol. 43(1): 44-50. https://doi.org/10.1053/j.semperi.2018.11.008; PMid:30527516 PMCid:PMC8015778
Leighton E, Chandraharan E. (2021, Dec). Management of Postpartum Haemorrhage. The EBCOG Postgraduate Textbook of Obstetrics & Gynaecology: 452-461. https://doi.org/10.1017/9781108863049.058
Lilley G, Burkett-St-Laurent D, Precious E, Bruynseels D, Kaye A, Sanders J et al. (2015). Measurement of blood loss during postpartum haemorrhage. Int J Obstet Anesth. 24(1): 8-14. https://doi.org/10.1016/j.ijoa.2014.07.009; PMid:25433576
Makarenko MM, Govsieiev DA, Aksenov VB. (2013). Efektyvna metodyka pry krovotechakh pid chas kesareva roztynu (RENYS II - remodeliuvannia nyzhnoho sehmenta matky). Health of woman. 4(80): 48-49.
MOZ Ukraïny. (2014). Pro zatverdzhennia klinichnykh protokoliv z akusherskoï ta hinekolohichnoï dopomohy. Nakaz MOZ Ukraïny No. 205 vid 24.03.2014. K: 82.
Muñoz M, Stensballe J, Ducloy-Bouthors AS, Bonnet MP, De Robertis E, Fornet I et al. (2019, Mar). Patient blood management in obstetrics: prevention and treatment of postpartum haemorrhage. A NATA consensus statement. Blood Transfus. 17(2): 112-136.
Pacheco LD, Saade GR, Costantine MM, Clark SL, Hankins GD. (2016). An update on the use of massive transfusion protocols in obstetrics. Am J Obstet Gynecol. 214(3): 340-344. https://doi.org/10.1016/j.ajog.2015.08.068; PMid:26348379
Pacheco LD, Saade GR, Gei AF et al. (2011). Cutting-edge advances in the medical management of obstetrical hemorrhage. Am J Obstet Gynecol. 205(6): 526-532. https://doi.org/10.1016/j.ajog.2011.06.009; PMid:21816382
Purwosunu Y, Sarkoen W, Arulkumaran S, Segnitz J. (2016). Control of postpartum hemorrhage using vacuum-induced uterine tamponade. Obstet Gynecol. 128: 33-36. https://doi.org/10.1097/AOG.0000000000001473; PMid:27275795
RCOG. (2016). Prevention and management of postpartum haemorrhage. Royal College of Obstetricians and Gynaecologists. Greentop Guideline No. 52 December 2016.
Schorn MN. (2010). Measurement of blood loss: review of the literature. J Midwifery Womens Health. 55(1): 20-27. https://doi.org/10.1016/j.jmwh.2009.02.014; PMid:20129226
Seifert SM, Lumbreras-Marquez MI, Goobie SM et al. (2022, Jun 6). Tranexamic Аcid administered during cesarean delivery in high-risk patients: maternal pharmacokinetics, pharmacodynamics, and coagulation status. Am. J. Obstet. Gynecol. S0002-9378(22)00441-0. https://doi.org/10.1016/j.ajog.2022.06.001; PMid:35679896
Stensæth KH, Carlsen MIS, Løvvik TS, Uleberg O, Brede JR, Søvik E. (2024, May). Resuscitative endovascular balloon occlusion of the aorta (REBOA) as adjunct treatment in life threatening postpartum hemorrhage: Fourteen years' experience from a single Norwegian center. Acta Obstet Gynecol Scand. 103(5): 965-969. Epub 2024 Jan 10. https://doi.org/10.1111/aogs.14767; PMid:38197478 PMCid:PMC11019522
Wormer KC, Jamil RT, Bryant SB. (2024). Postpartum Hemorrhage. Treasure Island (FL): StatPearls Publishing.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Ukrainian Journal Health of Woman
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal UKRAINIAN JOURNAL «HEALTH OF WOMAN» when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
